Potential Application of Marine Drugs in Oral Cancer Treatment
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 462
Special Issue Editors
Interests: natural product screening for anticancer; oxidative stress, antioxidant, DNA damage, apoptosis, selective killing, flow cytometry
Special Issues, Collections and Topics in MDPI journals
Interests: natural product chemistry on fungi; plants; marine organisms; comparative mass spectrometry-based metabolomics strategies for the investigation of natural products secondary metabolites; functional and healthy food; new drugs development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine natural products are the abundant resources for inhibiting cancer cell proliferation as well as migration and invasion. The development of crude extracts and bioactive compounds from the diverse species of marine resources is still in progress. A number of bioactive compounds from marine resources were isolated to provide drug candidates for anticancer screening.
Oral cancer is a global disease and its prevention and therapy are still challenging. The focus of this Special Issue is to highlight recent advances in identification from marine natural products against oral cancer cells. Moreover, the exploration of detailed anti-oral cancer mechanisms is encouraged, including apoptosis, autophagy, senescence, DNA damage, cell cycle disturbance, endoplasmic reticulum stress, and ferroptosis. Anti-oral cancer studies related to the combined treatment of marine natural products and clinical drugs or radiation are welcome.
We invite investigators to submit original and review articles that will identify novel marine natural products against oral cancer cells as well as explore their antioral cancer mechanisms. Head and neck cancer studies are also welcome.
Prof. Dr. Hsueh-Wei Chang
Prof. Fang-Rong Chang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
marine drugs; marine functional foods; secondary metabolites; algae; oxidative stress; antioxidant; DNA damage; apoptosis; autophagy; senescence; ferroptosis; selective killing; oral cancer; head and neck cancer; Laryngeal cancer
